OTTAWA (Reuters) – Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in developing the medicines.
“Canada is ready to discuss proposals on a waiver for intellectual property (IP) protection, particular to COVID-19 vaccines, under the WTO Agreement on TRIPS,” International Trade Minister Mary Ng said in a statement.
“Our government firmly believes in the importance of protecting IP and recognizes the integral role that industry has played in innovating to develop and deliver life-saving COVID-19 vaccines.”
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Need Your Help Today. Your $1 can change life.